Search results
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 2 days agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown...
Benzinga· 2 days agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 2 days agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 2 days agoRival developers of Covid-19 jabs have faced off at the High Court in London as a weeks-long trial...
COVID Vaccine Study Finds Small Signal of Seizure Risk in Young Kids
MedPage Today· 1 day agoData gathered from over 4 million children revealed that myocarditis or pericarditis occurred at...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 17 hours agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Some 700,000 Brits To Get Free Covid-19 Booster Shots This Week
Forbes· 4 days agoStarting Monday, the elderly and those with weakened immune systems will be able to get a shot free...
COVID Shot Boosts Mucosal Immunity in Previously Infected People
MedPage Today· 2 days agoOnly 'traces' of spike-specific salivary antibodies found in vaccinated SARS-CoV-2-naive people
mRNA Therapeutics Market is Estimated to be USD 45.85 billion by 2031; Driven by Innovative...
Digital Journal· 6 days agoAccording to SNS Insider, the mRNA Therapeutics market will be reaching USD 45.85 billion by 2031 and will be growing at a CAGR of 1.7% over the forecast period of 2024-2031. mRNA Therapeutics Market Market Scope The messenger ribonucleic acid (mRNA